Riskpilot← Back to searchSign inGet full accessSYNSENTERET DRAMMEN AS
ASActiveOrg 912236188Nedre Torggate 17, 3015 DrammenRetail sale of medical and orthopaedic goods · NACE 4774Est. 20139 employees
Revenue 2025
NOK 11,5M
+13% vs 2024
EBITDA margin
12.2%
+73% vs 2024
Equity ratio
50.0%
Financial strength
Net profit 2025
NOK 1,1M
+70% vs 2024
| Revenue | NOK 11,5M | +13% |
| EBITDA | NOK 1,4M | +73% |
| Net profit | NOK 1,1M | +70% |
| Total assets | NOK 5,2M | +7% |
| Equity | NOK 2,6M | +0% |
| Employees | 9 | — |
Legal name
SYNSENTERET DRAMMEN AS
Org number
912236188
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
24. juli 2013
Share capital
NOK 90 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Tillby optometriske og øyehelsetjenester samt å drive optisk forretning med optiske artikler.
Address
Nedre Torggate 17, 3015 Drammen
Phone
+4732831800
Email
syn@syndrammen.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8 469 | 8 462 | 10 298 | 10 152 | 11 454 |
| Staff expenses | −3 306 | −3 777 | −4 096 | −4 805 | −4 852 |
| EBITDA | 1 171 | 234 | 1 118 | 808 | 1 396 |
| Depreciation & amort. | −45 | −44 | −44 | −67 | −71 |
| EBIT | 1 126 | 190 | 1 074 | 741 | 1 325 |
| Net financials | 14 | 16 | 41 | 64 | 44 |
| Profit before tax | 1 140 | 205 | 1 115 | 805 | 1 370 |
| Tax | 248 | 39 | 258 | 181 | 307 |
| Net profit | 892 | 166 | 856 | 625 | 1 062 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 988 | 3 834 | 5 208 | 4 847 | 5 171 |
| Equity | 2 576 | 2 742 | 2 548 | 2 573 | 2 585 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 412 | 1 092 | 2 660 | 2 274 | 2 586 |
| Total debt | 1 412 | 1 092 | 2 660 | 2 274 | 2 586 |
EBITDA margin
12.2%
This company
15.8%
Market median
-23% vs market
20212025
Equity ratio
50.0%
This company
38.2%
Market median
+31% vs market
20212025
Return on equity
41.1%
This company
18.4%
Market median
+123% vs market
20212025
Net profit margin
9.3%
This company
8.1%
Market median
+15% vs market
20212025
Asset turnover
2.22×
This company
1.12×
Market median
+98% vs market
20212025
Debt / equity
1.00×
This company
0.62×
Market median
-61% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
AS Deputy Member | Deputy Member | 2015 |
RL Deputy Member | Deputy Member | 2015 |
ØL Deputy Member | Deputy Member | 2015 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2015 | |
| Board of Directors | 2015 | |
| Chairman | 2015 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SYNSENTERET DRAMMEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Solvang | Deputy Member | 0 companies |
| Roy Langengen | Deputy Member | 0 companies |
| Øystein Lauritzen | Deputy Member | 0 companies |
| Marianne Lauritzen | Board of Directors | 0 companies |
| Elisabeth Cordt-Hansen | Board of Directors | 0 companies |
| Ina Kristin Sundan | Chairman | 0 companies |